2020
DOI: 10.3389/fcell.2020.579513
|View full text |Cite
|
Sign up to set email alerts
|

The Interaction of TRAF6 With Neuroplastin Promotes Spinogenesis During Early Neuronal Development

Abstract: Correct brain wiring depends on reliable synapse formation. Nevertheless, signaling codes promoting synaptogenesis are not fully understood. Here, we report a spinogenic mechanism that operates during neuronal development and is based on the interaction of tumor necrosis factor receptor-associated factor 6 (TRAF6) with the synaptic cell adhesion molecule neuroplastin. The interaction between these proteins was predicted in silico and verified by co-immunoprecipitation in extracts from rat brain and co-transfec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 14 publications
(15 citation statements)
references
References 85 publications
0
15
0
Order By: Relevance
“…in glia (Langnaese et al 1997). Neuroplastin has been shown to interact as a ligand with the fibroblast growth factor (FGF) receptor (Owczarek et al 2010), gamma-aminobutyric acid type A (GABAA) receptors (Sarto-Jackson et al 2012), S100A8/A9, basigin (Sakaguchi et al 2016;Sumardika et al 2019), mesencephalic astrocyte-derived neurotrophic factor (MANF) (Yagi et al 2020), tumor necrosis factor receptor-associated factor 6 (TRAF6) (Vemula et al 2020), and with itself undergoing homophilic binding (Langnaese et al 1997;Owczarek et al 2010). Furthermore, plasma membrane trafficking of monocarboxylic acid transporter 2 (MCT-2, SLC16A7) and XK-related protein 8 (Xkr8) may require neuroplastin as chaperone (Wilson et al 2013;Suzuki et al 2016).…”
Section: Introductionmentioning
confidence: 99%
“…in glia (Langnaese et al 1997). Neuroplastin has been shown to interact as a ligand with the fibroblast growth factor (FGF) receptor (Owczarek et al 2010), gamma-aminobutyric acid type A (GABAA) receptors (Sarto-Jackson et al 2012), S100A8/A9, basigin (Sakaguchi et al 2016;Sumardika et al 2019), mesencephalic astrocyte-derived neurotrophic factor (MANF) (Yagi et al 2020), tumor necrosis factor receptor-associated factor 6 (TRAF6) (Vemula et al 2020), and with itself undergoing homophilic binding (Langnaese et al 1997;Owczarek et al 2010). Furthermore, plasma membrane trafficking of monocarboxylic acid transporter 2 (MCT-2, SLC16A7) and XK-related protein 8 (Xkr8) may require neuroplastin as chaperone (Wilson et al 2013;Suzuki et al 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, TRAF6 is proposed to play a role in Alzheimer's disease (AD) and neuroinflammation [86]. TRAF binding sites have been identified in neuroplastin [38,60] (see below, association of neuroplastin to cancer). In particular, we showed that the binding of TRAF6 to its binding motif (RKRPDEVPD) within the C-terminal domain of neuroplastin promotes spinogenesis [60].…”
Section: Neuroplastin Binding To Traf6mentioning
confidence: 99%
“…TRAF binding sites have been identified in neuroplastin [38,60] (see below, association of neuroplastin to cancer). In particular, we showed that the binding of TRAF6 to its binding motif (RKRPDEVPD) within the C-terminal domain of neuroplastin promotes spinogenesis [60]. Genetic inactivation of Nptn or TRAF6-RNA interference strongly reduced the protrusion density of young hippocampal neurons, which could be rescued by the over-expression of Np55 or Np65.…”
Section: Neuroplastin Binding To Traf6mentioning
confidence: 99%
See 2 more Smart Citations